Expression of Immune Checkpoint Markers PD-1, PD-L1, CD8, MSI, and p53 in Advanced Serous Ovarian Carcinoma

Autor: Ana Paula Dergham, Seigo Nagashima, Caroline Busatta Vaz de Paula, Marcia Olandoski, Lucia De Noronha, Vanessa Santos Sotomaior

Advanced high-grade serous ovarian carcinoma is a serious malignant neoplasm with a late diagnosis and high mortality rate. Even when treated with standard therapy, such as surgery followed by carboplatin and paclitaxel chemotherapy, the prognosis re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e910b5bd4f1bff009272e8f3de591b25
https://doi.org/10.20944/preprints202305.0173.v1

Distribuição dos diagnósticos de lesões pré-neoplásicas e neoplásicas de pele no Hospital Universitário Evangélico de Curitiba

Autor: Luiz Martins Collaço, Elisângela Aparecida Ramos, Lismary Mesquita, Ana Paula Dergham, Caren Cristiane Muraro

Publikováno v: Anais Brasileiros de Dermatologia v.79 n.5 2004
Anais brasileiros de dermatologia
Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
Anais Brasileiros de Dermatologia, Volume: 79, Issue: 5, Pages: 555-559, Published: OCT 2004

FUNDAMENTOS: O câncer de pele é mais comum nas populações de pele branca. Quanto aos tumores de pele, o CBC é o mais freqüente. Das lesões pré-cancerosas, a que ocorre com mais freqüência é a ceratose actínica, que se torna maligna em per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7f2a14e57b1aec7d25bbf5145382f6
https://doi.org/10.1590/s0365-05962004000500005

Research on Ovarian Cancer Discussed by a Researcher at Pontifical Catholic University of Parana (PUCPR) (Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A...).

Publikováno v: Women's Health Weekly; 7/11/2023, p996-996, 1p